Boyalife Investment Fund I, Inc. - Net Worth and Insider Trading
Boyalife Investment Fund I, Inc. Net Worth
The estimated net worth of Boyalife Investment Fund I, Inc. is at least $4 Million dollars as of 2024-11-08. Boyalife Investment Fund I, Inc. is the 10% Owner of Nuo Therapeutics Inc and owns about 4,900,000 shares of Nuo Therapeutics Inc (AURX) stock worth over $4 Million. Details can be seen in Boyalife Investment Fund I, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Boyalife Investment Fund I, Inc. has not made any transactions after 2017-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Boyalife Investment Fund I, Inc.
Boyalife Investment Fund I, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Boyalife Investment Fund I, Inc. owns 1 companies in total, including Nuo Therapeutics Inc (AURX) .
Insider Ownership Summary of Boyalife Investment Fund I, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AURX | Nuo Therapeutics Inc | 2017-09-11 | 10 percent owner |
Boyalife Investment Fund I, Inc. Latest Holdings Summary
Boyalife Investment Fund I, Inc. currently owns a total of 1 stock. Boyalife Investment Fund I, Inc. owns 4,900,000 shares of Nuo Therapeutics Inc (AURX) as of September 11, 2017, with a value of $4 Million.
Latest Holdings of Boyalife Investment Fund I, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AURX | Nuo Therapeutics Inc | 2017-09-11 | 4,900,000 | 0.79 | 3,871,000 |
Holding Weightings of Boyalife Investment Fund I, Inc.
Boyalife Investment Fund I, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Boyalife Investment Fund I, Inc. has made a total of 0 transactions in Nuo Therapeutics Inc (AURX) over the past 5 years. The most-recent trade in Nuo Therapeutics Inc is the acquisition of 3,150,000 shares on September 11, 2017, which cost Boyalife Investment Fund I, Inc. around $693,000.
Insider Trading History of Boyalife Investment Fund I, Inc.
- 1
Boyalife Investment Fund I, Inc. Trading Performance
Boyalife Investment Fund I, Inc. Ownership Network
Ownership Network List of Boyalife Investment Fund I, Inc.
Ownership Network Relation of Boyalife Investment Fund I, Inc.
Boyalife Investment Fund I, Inc. Owned Company Details
What does Nuo Therapeutics Inc do?
Who are the key executives at Nuo Therapeutics Inc?
Boyalife Investment Fund I, Inc. is the 10 percent owner of Nuo Therapeutics Inc. Other key executives at Nuo Therapeutics Inc include 10 percent owner Charles E Sheedy , director & CEO & CFO David Emerson Jorden , and CSO Peter Clausen .
Nuo Therapeutics Inc (AURX) Insider Trades Summary
Over the past 18 months, Boyalife Investment Fund I, Inc. made no insider transaction in Nuo Therapeutics Inc (AURX). Other recent insider transactions involving Nuo Therapeutics Inc (AURX) include a net purchase of 437,500 shares made by Charles E Sheedy ,
In summary, during the past 3 months, insiders sold 0 shares of Nuo Therapeutics Inc (AURX) in total and bought 125,000 shares, with a net purchase of 125,000 shares. During the past 18 months, 0 shares of Nuo Therapeutics Inc (AURX) were sold and 437,500 shares were bought by its insiders, resulting in a net purchase of 437,500 shares.
Nuo Therapeutics Inc (AURX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuo Therapeutics Inc Insider Transactions
Boyalife Investment Fund I, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Boyalife Investment Fund I, Inc.. You might contact Boyalife Investment Fund I, Inc. via mailing address: 2453 S. Archer Ave., Suite B, Chicago Il 60616.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
